Urology · Jeffersonville, IN
NPI
1710001607
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
101 Hospital Blvd
Jeffersonville, IN, 47130
Phone (812) 282-3899
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
15,575 services
Medicare patients, 2024
1,911
Average age 73
Drug cost, 2024
$677K
4,135 prescriptions
Company payments, 2025
$1,283
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles J Goodwin was code J9030 (bcg live intravesical instillation, 1 mg), 2,127 times for 15 patients. In total Charles J Goodwin billed 15,575 services in 134 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,127 | 15 | $2.23 | $4,739 |
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 14 | $18.70 | $26K |
| 81003 Clinical Chemistry | Office | 1,321 | 874 | $2.18 | $2,885 |
| 99214 Office E&M - Established | Office | 1,188 | 833 | $84.30 | $100K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,050 | 21 | $44.16 | $46K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 938 | 187 | $43.00 | $40K |
| 84153 Clinical Chemistry | Office | 402 | 304 | $17.98 | $7,228 |
| 99232 Hospital E&M - Subsequent | Facility | 330 | 151 | $57.92 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 292 | 268 | $10.24 | $2,992 |
| 51798 Ultrasound - Nonspecific | Office | 256 | 211 | $7.49 | $1,918 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 227 | 102 | $34.88 | $7,917 |
| 99213 Office E&M - Established | Office | 222 | 204 | $58.19 | $13K |
| 74018 Standard X-ray | Office | 206 | 188 | $13.19 | $2,717 |
| 99222 Hospital E&M - Initial | Facility | 177 | 168 | $95.04 | $17K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 133 | 133 | $43.64 | $5,804 |
By year: 2022 $1.0M for 20,696 services; 2023 $1.1M for 16,272 services; 2024 $1.2M for 15,575 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,321 | 874 | $2.18 | $2,885 |
| 84153 Clinical Chemistry | 402 | 304 | $17.98 | $7,228 |
| 36415 Venipuncture Blood Collection | 121 | 121 | $8.65 | $1,047 |
| 82565 Clinical Chemistry | 105 | 105 | $5.02 | $527 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 12 | 12 | $18.92 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles J Goodwin prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,287 prescriptions and refills. In total Charles J Goodwin wrote 4,135 Medicare prescriptions that cost $677K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,287 | 3,282 | 405 | $17K |
| Gemtesa Vibegron | 369 | 646 | 86 | $298K |
| Finasteride Generic | 350 | 974 | 107 | $4,166 |
| Myrbetriq Mirabegron | 295 | 644 | 81 | $283K |
| Cephalexin Generic | 244 | 358 | 140 | $1,722 |
| Trimethoprim Generic | 167 | 406 | 62 | $13K |
| Ciprofloxacin Hcl Generic | 162 | 162 | 150 | $664 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 140 | 140 | 115 | $964 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 105 | 119 | 83 | $1,394 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 83 | 121 | 57 | $485 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 74 | 74 | 60 | $467 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 72 | 158 | 26 | $2,515 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 52 | 112 | 13 | $894 |
| Testosterone Generic | 50 | 70 | 13 | $14K |
| Dutasteride Generic | 47 | 141 | 15 | $748 |
Brand drugs: - claims; generic drugs: 3,290 claims; opioid claims: 174.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles J Goodwin $1,283 ($1,283 in general payments such as food, travel and fees) from 11 companies. The largest payer was Medtronic, Inc. with $788.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 14 | $788 |
| Sumitomo Pharma America, Inc. 4506.T | 11 | $151 |
| Accord Healthcare, Inc. | 2 | $124 |
| Abbvie Inc. ABBV | 3 | $71.55 |
| Urogen Pharma, Inc. URGN | 2 | $55.33 |
| Boston Scientific Corporation BSX | 1 | $25.4 |
| Verity Pharmaceuticals Inc. | 1 | $18.72 |
| Merck Sharp & Dohme LLC MRK | 1 | $17.85 |
| Endo USA, Inc. | 1 | $16.3 |
| Immunitybio, Inc. IBRX | 1 | $13.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.